PTK2 and breast cancer: The data suggest that CRF (produced in tumor cells and/or in normal cells of the tumor microenvironment and/or released from nerve terminals and/or arising from the blood stream) promoted the migration of BC cells through actin filament reorganization and the activation of FAK phosphorylation and prostaglandin production via Cox-1.